PR Newswire Financial
prCenter
REPL DEADLINE: SueWallSt Reminds Replimune Group, Inc. Investors of Upcoming Securities Class Action Deadlinetranslating…
Alert: Replimune shares collapsed from a $10.73 Class Period high to $1.70 following the FDA's rejection of the RP1 biologics license application, a cumulative decline of roughly 84% that the complaint alleges followed disclosures correcting earlier statements about the…
Keywords#DEADLINE#Class#Replimune#Action#Action Deadline
Comments
Sign in to join the discussion.
Loading comments…